BAY1902607
Sponsors
Bayer
Conditions
Clinical Trials, Phase I as TopicCoughDrug Interactions
Phase 1
BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food Effect
CompletedNCT03212586
Start: 2017-07-18End: 2018-07-27Updated: 2019-05-14
Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients
CompletedNCT03535168
Start: 2018-05-29End: 2019-10-11Updated: 2021-02-10
Study to Learn More About the Effect of Itraconazole (ITZ) Given Repeatedly by Mouth on the Way How the Study Drug BAY1902607 Given One Time by Mouth Acts in the Human Body of Healthy Male Participants
CompletedNCT03789890
Start: 2019-01-08End: 2019-05-23Updated: 2019-05-29